Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging

In situ ATR-FTIR spectroscopy and imaging and image analysis were applied to the study of the multicomponent co-crystallization process involving <i>S</i>-valsartan and sacubitril in which LCZ696 crystals were formed. LCZ696 is a combination drug for use in heart failure that was approve...

Full description

Bibliographic Details
Main Authors: Xiao Juan Liu, Yang Zhang, Xue Zhong Wang
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Crystals
Subjects:
Online Access:https://www.mdpi.com/2073-4352/10/10/922
_version_ 1797551309514080256
author Xiao Juan Liu
Yang Zhang
Xue Zhong Wang
author_facet Xiao Juan Liu
Yang Zhang
Xue Zhong Wang
author_sort Xiao Juan Liu
collection DOAJ
description In situ ATR-FTIR spectroscopy and imaging and image analysis were applied to the study of the multicomponent co-crystallization process involving <i>S</i>-valsartan and sacubitril in which LCZ696 crystals were formed. LCZ696 is a combination drug for use in heart failure that was approved by the FDA in 2015 following development by Novartis Pharmaceuticals. Though much work was reported on LCZ696 about its pharmacokinetic and pharmacodynamic effects in the evaluation and clinical testing, less attention was paid to study on the co-crystallization process. LCZ696 crystals have shown difficulties in filtration mainly due to the small particle size. In this work, LCZ696 crystals were prepared successfully by <i>S</i>-valsartan and sacubitril, and characterized by SEM, XRPD, TG-DSC and ATR-FTIR. ATR-FTIR and imaging and image analysis were used to monitoring solution concentration and investigating the co-crystallization mechanism. It revealed that the nucleation process was very slow compared with the transformation process, which is indication that the co-crystallization was controlled by nucleation. LCZ696 crystals are composed of very thin hexagonal plates, which seems indicating that LCZ696 crystals grow mainly in two size dimensions. Stirrer speed and crystal seeds were found to have noticeable effect on the induction time, transformation time and crystal size distribution. The Johnson-Mehl-Avrami equation was found to be able to describe the co-crystallization process.
first_indexed 2024-03-10T15:42:48Z
format Article
id doaj.art-be4833378de74ced93b21d7b624fb3be
institution Directory Open Access Journal
issn 2073-4352
language English
last_indexed 2024-03-10T15:42:48Z
publishDate 2020-10-01
publisher MDPI AG
record_format Article
series Crystals
spelling doaj.art-be4833378de74ced93b21d7b624fb3be2023-11-20T16:40:52ZengMDPI AGCrystals2073-43522020-10-01101092210.3390/cryst10100922Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and ImagingXiao Juan Liu0Yang Zhang1Xue Zhong Wang2School of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, ChinaSchool of Chemistry and Chemical Engineering, South China University of Technology, Guangzhou 510641, ChinaLaboratory for Pharmaceutical and Crystallization Systems Engineering, Beijing Key Laboratory of Enze Biomass Fine Chemicals, School of Chemical Engineering, Beijing University of Petrochemical Technology, Beijing 102617, ChinaIn situ ATR-FTIR spectroscopy and imaging and image analysis were applied to the study of the multicomponent co-crystallization process involving <i>S</i>-valsartan and sacubitril in which LCZ696 crystals were formed. LCZ696 is a combination drug for use in heart failure that was approved by the FDA in 2015 following development by Novartis Pharmaceuticals. Though much work was reported on LCZ696 about its pharmacokinetic and pharmacodynamic effects in the evaluation and clinical testing, less attention was paid to study on the co-crystallization process. LCZ696 crystals have shown difficulties in filtration mainly due to the small particle size. In this work, LCZ696 crystals were prepared successfully by <i>S</i>-valsartan and sacubitril, and characterized by SEM, XRPD, TG-DSC and ATR-FTIR. ATR-FTIR and imaging and image analysis were used to monitoring solution concentration and investigating the co-crystallization mechanism. It revealed that the nucleation process was very slow compared with the transformation process, which is indication that the co-crystallization was controlled by nucleation. LCZ696 crystals are composed of very thin hexagonal plates, which seems indicating that LCZ696 crystals grow mainly in two size dimensions. Stirrer speed and crystal seeds were found to have noticeable effect on the induction time, transformation time and crystal size distribution. The Johnson-Mehl-Avrami equation was found to be able to describe the co-crystallization process.https://www.mdpi.com/2073-4352/10/10/922<i>S</i>-valsartan and sacubitril co-crystallizationLCZ696ATR-FTIROn-line process imaging
spellingShingle Xiao Juan Liu
Yang Zhang
Xue Zhong Wang
Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging
Crystals
<i>S</i>-valsartan and sacubitril co-crystallization
LCZ696
ATR-FTIR
On-line process imaging
title Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging
title_full Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging
title_fullStr Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging
title_full_unstemmed Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging
title_short Study on Co-Crystallization of LCZ696 Using In Situ ATR-FTIR and Imaging
title_sort study on co crystallization of lcz696 using in situ atr ftir and imaging
topic <i>S</i>-valsartan and sacubitril co-crystallization
LCZ696
ATR-FTIR
On-line process imaging
url https://www.mdpi.com/2073-4352/10/10/922
work_keys_str_mv AT xiaojuanliu studyoncocrystallizationoflcz696usinginsituatrftirandimaging
AT yangzhang studyoncocrystallizationoflcz696usinginsituatrftirandimaging
AT xuezhongwang studyoncocrystallizationoflcz696usinginsituatrftirandimaging